Cancer drug eliminates aggressive cancers in Phase I trial
August 14, 2025
Over the past 20 years, a class of cancer drugs called CD40 agonist antibodies have shown great promise—and induced great disappointment.
Over the past 20 years, a class of cancer drugs called CD40 agonist antibodies have shown great promise—and induced great disappointment.
Scientists at the University of Virginia School of Medicine and the University of Michigan have developed a monoclonal antibody to stop sepsis, a deadly full-body infection.
WEST DUNDEE, Ill., Aug. 14, 2025 /PRNewswire/ — Those seeking help with depression or anxiety can now benefit from an FDA-cleared, medication-free procedure at Dundee Dermatology. The center is showcasing EXOMIND, a noninvasive neurostimulation device that enhances mental wellness.
The team used two different AI approaches to design novel antibiotics, including one that showed promise against MRSA.
The test was previously granted a breakthrough device designation by the US regulator.
Apple said it was able to bring a redesigned blood oxygen feature to its devices after a recent U.S. customs ruling.
Researchers at Arizona State University have developed a breakthrough diagnostic tool that could transform how quickly and reliably we detect illnesses like COVID-19, Ebola, AIDS or Lyme disease.
Now, researchers publishing in ACS Applied Polymer Materials have created a reusable hydrogel that releases artificial saliva over time, which could help provide sustained relief from dry mouth.
Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School of Medicine and the Wharton School at the University of Pennsylvania can analyze kidney disease at the cellular level to match the most effective treatments and speed up solutions.
Ovarian cancer is the leading cause of death among women with gynecological cancers. The current medical playbook—surgery followed by chemotherapy—initially shows promise.